|
|
Active Biotech AB - Comparative Business Analysis Snapshot
Business Description
Active Biotech AB. The Group's principal activity is to develop pharmaceuticals and vaccines for infectious and auto immune as well as inflammatory disease. The Group portfolio includes innovative substances that modulate the human immune system. It also develops products designed to treat multiple sclerosis, as well as lung, renal and pancreatic cancer.The group has a patent portfolio that comprises 23 strategic patent families in key projects.
Competitor Analysis
This analysis compares Active Biotech AB with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
